These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22227071)

  • 21. Nampt and its potential role in inflammation and type 2 diabetes.
    Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W
    Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.
    Radetti G; Kleon W; Stuefer J; Pittschieler K
    Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity.
    Esteghamati A; Alamdari A; Zandieh A; Elahi S; Khalilzadeh O; Nakhjavani M; Meysamie A
    Diabetes Res Clin Pract; 2011 Feb; 91(2):154-8. PubMed ID: 21122936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids.
    Siahanidou T; Margeli A; Kappis A; Papassotiriou I; Mandyla H
    Metabolism; 2011 Mar; 60(3):389-93. PubMed ID: 20359723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of postprandial lipemia on plasma concentrations of A-FABP, RBP-4 and visfatin.
    Ciardi C; Tatarczyk T; Tschoner A; Kranebitter M; Niederwanger A; Ebenbichler CF; Patsch JR; Pedrini MT
    Nutr Metab Cardiovasc Dis; 2010 Nov; 20(9):662-8. PubMed ID: 19699625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lipoprotein Lp(a) in obesity.
    Donatelli M; Verga S; Vaccaro M; Russo V; Bucalo ML; Scarpinato A
    Diabetes Res; 1992; 20(4):127-31. PubMed ID: 1345006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
    Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults.
    Kim SH; Lee JW; Hwang HJ
    Asia Pac J Clin Nutr; 2011; 20(1):14-20. PubMed ID: 21393105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early diabetic metabolism anomalies and bioptically objectified degree of fatty degeneration of the liver in biliary calculi patients].
    Kremer GJ; Knick B; Lange HJ; Kössling FK; Grams H
    Schweiz Med Wochenschr; 1968 Jan; 98(4):110-4. PubMed ID: 5670493
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum resistin is related to plasma HDL cholesterol and inversely correlated with LDL cholesterol in diabetic and obese humans.
    Owecki M; Nikisch E; Miczke A; Pupek-Musialik D; Sowiński J
    Neuro Endocrinol Lett; 2010; 31(5):673-8. PubMed ID: 21173741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis.
    Muscari A; Berzigotti A; Bianchi G; Giannoni C; Ligabue A; Magalotti D; Sbano D; Zacchini A; Zoli M
    Eur J Heart Fail; 2006 Aug; 8(5):468-76. PubMed ID: 16386463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.
    Jin HB; Gu ZY; Yu CH; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):389-92. PubMed ID: 16109522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.